NAM logo
  • site map
  • contact
  • advanced search
  • Home
  • News
  • Treatment & Care
  • HIV Worldwide
  • Living with HIV
  • Preventing HIV
  • Organisations
  • HIV Basics
  • About Us
 
Treatment & Care
  • español
  • français
  • português
  • pусский
Starting HIV treatment
  • When to start treatment
    • Choosing a combination
      • Summary: Choosing a combination
      • What to start with
      • Choosing a nucleoside or nucleotide reverse transcriptase inhibitor backbone
      • Choosing a protease inhibitor
      • Choosing a non-nucleoside reverse transcriptase inhibitor
      • Other options
      • Options for simplifying therapy
      • Questions to ask your doctor
    support our work today
    YOU ARE HERE
    • > Home
      • > Treatment & Care
        • > Treatment & Care
          • > Starting HIV treatment

    Choosing a combination

    printer-friendly versionsend to a friendglossarycomment

    Details of how to choose an appropriate treatment combination, including the choice of drugs from each class, newer classes of drugs, and options for simplifying therapy.

    • Summary: Choosing a combination
    • What to start with
    • Choosing a nucleoside or nucleotide reverse transcriptase inhibitor backbone
    • Choosing a protease inhibitor
    • Choosing a non-nucleoside reverse transcriptase inhibitor
    • Other options
    • Options for simplifying therapy
    • Questions to ask your doctor

    latest aidsmap news

    • Unsuccessful post-exposure prophylaxis may still result in weaker HIV infection and lower viral load
    • Jury still out on whether circumcision protects gay men against HIV
    • Antiretroviral therapy does not fully reverse impact of HIV on hepatitis C-related cirrhosis
    • High early mortality after starting antiretroviral treatment in Africa
    • Nobel prize awarded to French discoverers of HIV
    • Fall in number of undiagnosed HIV infections in the US
    • Resistance to darunavir related to pre-existing mutations
    • Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis
    • Wide variation found in anal HPV viral loads in HIV-positive men
    • Offering rapid point-of-care tests would increase uptake of HIV testing
     
    • Contact NAM
    • Get Email Updates
    • Disclaimer
    • Copyright
    • Developed By NAM